Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Other hematologic neoplasm 2Lymphoid 2Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Leukemia, Biphenotypic, Acute 12Leukemia, Myeloid, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Osteosarcoma 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Blast Crisis 4Lymphoma, Mantle-Cell 3Lymphoma 3Down Syndrome 3Blastic Plasmacytoid Dendritic Cell Neoplasm 3Rhabdoid Tumor 2Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Head and Neck Neoplasms 2Anemia, Refractory, with Excess of Blasts 2Waldenstrom Macroglobulinemia 1Urothelial Carcinoma of the Bladder 1Urinary Bladder Neoplasms 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1

Interventions

Cyclophosphamide 5fludarabine phosphate 3Methotrexate 3merphos 2fludarabine 2Whole-Body Irradiation 2Thiotepa 2Tacrolimus 2Rituximab 2Mycophenolic Acid 2venetoclax 1tagraxofusp 1prednylidene 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1deltacortene 1azathiopurine 1auricularum 1Vincristine 1Sirolimus 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone 1Mesna 1Mercaptopurine 1Medrol Veriderm 1Doxorubicin 1Dexamethasone 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × Methotrexate × 90 days × Clear all
NCT02220985 2026-06-01

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Fred Hutchinson Cancer Center

Phase 2 Completed
84 enrolled 22 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04216524 2026-04-14

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡